19-Norcholesta-1,3,5(10),6,23-pentaen-11-one,2-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-3,16,20,22,25-pentahydroxy-4,9,14-trimethyl-,(9b,16a,23E)- (159650-32-5)

Identification
Name:	19-Norcholesta-1,3,5(10),6,23-pentaen-11-one,2-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-3,16,20,22,25-pentahydroxy-4,9,14-trimethyl-,(9b,16a,23E)-
Synonyms:	(-)-CabenosideB; Cabenoside B
CAS:	159650-32-5
Molecular Formula:	C41H60 O17
Molecular Structure:
Properties
Safety Data

Other Product

19-Norcholesta-1,3,5(10),6,23-pentaen-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22,25-pentahydroxy-4,9,14-trimethyl-,(9b,16a,23E)-
19-Norcholesta-1,3,5(10),23-tetraen-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22,25-pentahydroxy-4,9,14-trimethyl-,(9b,16a,23E)- (9CI)
19-Norcholesta-1,3,5(10),23-tetraen-11-one,25-butoxy-2-(b-D-glucopyranosyloxy)-3,16,20,22-tetrahydroxy-4,9,14-trimethyl-,(9b,16a,23E)- (9CI)
19-Norlanost-5-en-24-one,3-[(6-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-25-(b-D-glucopyranosyloxy)-11-hydroxy-9-methyl-,(3b,9b,10a,11a)-
19-Norcholesta-1,3,5(10),6,23,25-hexaen-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22-tetrahydroxy-4,9,14-trimethyl-,(9b,16a,23E)-
19-Norcholesta-1,3,5(10),23,25-pentaen-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22-tetrahydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
19-Norcholesta-1,3,5(10),23-tetraen-11-one,2,3,16,20,22-pentahydroxy-25-methoxy-4,9,14-trimethyl-, (9b,16a,22S,23E)- (9CI)
19-Norcholesta-1,3,5(10),23-tetraen-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22-tetrahydroxy-25-methoxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
19-Norcholesta-1,3,5(10),23-tetraene-11,22-dione,2-(b-D-glucopyranosyloxy)-3,16,20,25-tetrahydroxy-4,9,14-trimethyl-,(9b,16a,23E)- (9CI)
19-Norcholesta-1,3,5(10)-trien-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22,25-pentahydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
Lanosta-9(11),25-dien-18-oicacid, 20-hydroxy-3-[(O-3-O-methyl-b-D-glucopyranosyl-(1®3)-O-b-D-glucopyranosyl-(1®4)-O-[O-3-O-methyl-b-D-glucopyranosyl-(1®3)-O-b-D-glucopyranosyl-(1®4)-6-deoxy-b-D-glucopyranosyl-(1®2)]-b-D-xylopyranosyl)oxy]-16-oxo-, g-lactone, (3b)-
19-Norcholesta-1,3,5(10),23-tetraen-11-one,2,3,16,20,25-pentahydroxy-4,9,14-trimethyl-, (9b,16a,23E)- (9CI)
19-Norlanost-5-en-24-one,3-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-25-(b-D-glucopyranosyloxy)-11-hydroxy-9-methyl-,(3b,9b,10a,11a)- (9CI)
Cholest-9(11)-en-23-one,6-[(O-6-deoxy-b-D-galactopyranosyl-(1®4)-O-[b-D-xylopyranosyl-(1®2)]-O-b-D-glucopyranosyl-(1®4)-O-[6-deoxy-b-D-glucopyranosyl-(1®2)]-O-6-deoxy-b-D-glucopyranosyl-(1®3)-6-deoxy-b-D-glucopyranosyl)oxy]-20-hydroxy-3-(sulfooxy)-,monosodium salt, (3b,5a,6a)- (9CI)
19-Norlanost-5-en-11-one,3-[[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-25-(b-D-glucopyranosyloxy)-24-hydroxy-9-methyl-,(3b,9b,10a)- (9CI)
19-Norlanost-5-en-11-one,25-[(6-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-3-(b-D-glucopyranosyloxy)-24-hydroxy-9-methyl-,(3b,9b,10a,24R)- (9CI)
Cholest-9(11)-en-23-one,6-[(O-a-L-arabinopyranosyl-(1®4)-O-[6-deoxy-b-D-galactopyranosyl-(1®2)]-O-b-D-glucopyranosyl-(1®4)-O-[6-deoxy-b-D-glucopyranosyl-(1®2)]-O-6-deoxy-b-D-glucopyranosyl-(1®3)-6-deoxy-b-D-glucopyranosyl)oxy]-20-hydroxy-3-(sulfooxy)-,monosodium salt, (3b,5a,6a,20S)- (9CI)
19-Norcholesta-1,3,5(10),6-tetraene-11,22-dione,25-(acetyloxy)-2-(b-D-glucopyranosyloxy)-3,16,20-trihydroxy-4,9,14-trimethyl-, (9b,16a)-
Cholest-9(11)-en-23-one,6-[(O-6-deoxy-b-D-glucopyranosyl-(1®2)-O-[O-b-D-galactopyranosyl-(1®3)-O-6-deoxy-b-D-galactopyranosyl-(1®2)-b-D-galactopyranosyl-(1®4)]-O-6-deoxy-b-D-glucopyranosyl-(1®3)-6-deoxy-b-D-glucopyranosyl)oxy]-20-hydroxy-3-(sulfooxy)-, (3b,5a,6a)- (9CI)
Stigmast-9(11)-en-23-one,6-[(O-6-deoxy-b-D-galactopyranosyl-(1®3)-O-6-deoxy-b-D-galactopyranosyl-(1®2)-O-b-D-glucopyranosyl-(1®4)-O-[6-deoxy-b-D-glucopyranosyl-(1®2)]-O-b-D-xylopyranosyl-(1®3)-6-deoxy-b-D-glucopyranosyl)oxy]-20-hydroxy-3-(sulfooxy)-,monosodium salt, (3b,5a,6a)- (9CI)